John Northcott - Net Worth and Insider Trading
John Northcott Net Worth
The estimated net worth of John Northcott is at least $294,637 dollars as of 2024-11-13. John Northcott is the SVP & Chief Commercial Officer of Nektar Therapeutics and owns about 223,210 shares of Nektar Therapeutics (NKTR) stock worth over $294,637. Details can be seen in John Northcott's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Northcott has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Northcott
John Northcott Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Northcott owns 2 companies in total, including Nektar Therapeutics (NKTR) , and Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of John Northcott’s form 4 insider trades.
Insider Ownership Summary of John Northcott
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2022-05-16 | SVP & Chief Commercial Officer |
| LXRX | Lexicon Pharmaceuticals Inc | 2014-07-24 | VP & Marketing & Comm Strategy |
John Northcott Latest Holdings Summary
John Northcott currently owns a total of 1 stock. John Northcott owns 223,210 shares of Nektar Therapeutics (NKTR) as of May 16, 2022, with a value of $294,637.
Latest Holdings of John Northcott
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2022-05-16 | 223,210 | 1.32 | 294,637 |
Holding Weightings of John Northcott
John Northcott Form 4 Trading Tracker
According to the SEC Form 4 filings, John Northcott has made a total of 6 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Nektar Therapeutics is the sale of 4,592 shares on May 16, 2022, which brought John Northcott around $18,138.
Insider Trading History of John Northcott
- 1
John Northcott Trading Performance
John Northcott Ownership Network
Ownership Network List of John Northcott
Ownership Network Relation of John Northcott
John Northcott Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
John Northcott is the SVP & Chief Commercial Officer of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, John Northcott made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
John Northcott Mailing Address
Above is the net worth, insider trading, and ownership report for John Northcott. You might contact John Northcott via mailing address: 455 Mission Bay Boulevard South, C/o Nektar Therapeutics, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
